What does Deciphera Pharmaceuticals, Inc. do?

Jun 22 2025 06:58 PM IST
share
Share Via
Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments. As of March 2024, it reported net sales of $45 million and a net loss of $45 million, with a market cap of approximately $2.21 billion.
Overview:
Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company in the biotechnology industry, focused on developing drugs to improve the lives of cancer patients. Financial Snapshot: Most recent Net Sales: 45 Million (Quarterly Results - Mar 2024) Most recent Net Profit: -45 Million (Quarterly Results - Mar 2024) Market-cap: USD 2,212.92 Million (Micro Cap) Key Metrics: P/E: NA (Loss Making) Industry P/E: NA Dividend Yield: 9,118.37% Debt Equity: -0.85 Return on Equity: -60.25% Price to Book: 7.00 Contact Details: Address: 200 Smith St, WALTHAM MA: 02451-0099 Tel: ['1 781 2096400', '1 212 6001902'] Fax: 1 302 6555049 Website: https://www.deciphera.com
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News